MetaCap

Adial Pharmaceuticals (ADIL) vs Jaguar Health (JAGX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Adial Pharmaceuticals is the larger company by market cap ($10.4 million vs $8.8 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

ADIL versus JAGX key metrics
MetricADILJAGX
Share price$3.97$4.53
Market cap$10.42M$8.81M
1-day change-0.50%-9.40%
YTD return-27.45%—
1-year return-59.08%—
5-year return-99.84%—
EPS (TTM)$-20.65$-4,012.65
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$10.75$1,267.88
52-week low$1.31$2.35
Distance from 52-week high-63.07%-99.64%
Average volume56.77K2.00M
Shares outstanding2.63M1.95M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

ADIL vs JAGX FAQ

Which is bigger, Adial Pharmaceuticals or Jaguar Health?

Adial Pharmaceuticals (ADIL) is larger, with a market capitalization of $10.42M compared with $8.81M for Jaguar Health (JAGX).

Are Adial Pharmaceuticals and Jaguar Health in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons